Details for New Drug Application (NDA): 087996
✉ Email this page to a colleague
NDA 087996 describes MYMETHAZINE FORTIS, which is a drug marketed by Usl Pharma and is included in one NDA. Additional details are available on the MYMETHAZINE FORTIS profile page.
The generic ingredient in MYMETHAZINE FORTIS is promethazine hydrochloride. There are twelve drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
The generic ingredient in MYMETHAZINE FORTIS is promethazine hydrochloride. There are twelve drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
Summary for 087996
| Tradename: | MYMETHAZINE FORTIS |
| Applicant: | Usl Pharma |
| Ingredient: | promethazine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087996
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 25MG/5ML | ||||
| Approval Date: | Jan 18, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
